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The vascular system is lined with endothelial cells that serve as 
a barrier separating blood from underlying tissues. Maintenance 
and modulation of endothelial barrier function is necessary 
to control the movement of nutrients, fl  uids, and immune cells 
between the intravascular and extravascular compartments. 
Barrier function requires cell–cell interactions, mediated in 
large part by adherens and tight junctions, which act to restrict 
the passage of material between cells in the endothelial lining 
(Corada et al., 1999; Hordijk et al., 1999). Loss of cell–cell 
junctional integrity in the endothelial lining results in increased 
permeability and edema (Wysolmerski et al., 1984; Wysolmerski 
and Lagunoff, 1985; Rotrosen and Gallin, 1986).
Both adherens and tight junctions use transmembrane 
proteins that interact with homotypic receptors on neighboring 
cells. Ligation of these receptors stimulates the cytoplasmic 
  recruitment of multiprotein complexes that are involved in signal 
transduction and interaction with the cytoskeleton. Endothelial 
adherens junctions are formed by the homophilic interaction of 
transmembrane VE-cadherin molecules (Dejana et al., 1999). 
The intracellular domain of vascular endothelial–cadherin (VE-
cadherin) interacts with β-catenin and recruits molecules such 
as plakoglobin, α-catenin, zyxin, p120 catenin, and vinculin 
(Aberle et al., 1996; Pokutta and Weis, 2002; Bazzoni and 
Dejana, 2004). Tight junctions contain several transmembrane 
components, including occludin, claudins, and junctional adhe-
sion molecule-A (Martin-Padura et al., 1998; Mitic and Anderson, 
1998). These interact with intracellular components such as the 
zonula occludens (ZO) proteins (ZO-1, ZO-2, and ZO-3) and 
AF-6/Afadin.
Functionally, cell–matrix associations, such as focal adhe-
sions, are similar to cell–cell junctions in that they link the cyto-
skeleton with external contact points and are important for 
barrier function (Wu, 2005). In focal adhesions, transmembrane 
integrin receptors bind extracellular matrix and recruit intracel-
lular multiprotein complexes that interact with the cytoskeleton. 
Many of the proteins found in focal adhesions are also present 
in cell–cell junctions.
Members of the Enabled/vasodilator-stimulated phospho-
protein (Ena/VASP) family of actin regulatory proteins are found at 
both focal adhesions and cell–cell junctions, where they interact 
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nabled/vasodilator-stimulated phosphoprotein (Ena/
VASP) proteins are key actin regulators that localize 
at regions of dynamic actin remodeling, including 
cellular protrusions and cell–cell and cell–matrix junctions. 
Several studies have suggested that Ena/VASP proteins are 
involved in the formation and function of cellular junctions. 
Here, we establish the importance of Ena/VASP in endo-
thelial junctions in vivo by analysis of Ena/VASP-deﬁ  cient 
animals. In the absence of Ena/VASP, the vasculature 
exhibits patterning defects and lacks structural integrity, 
leading to edema, hemorrhaging, and late stage embry-
onic lethality. In endothelial cells, we ﬁ  nd that Ena/VASP 
activity is required for normal F-actin content, actomyosin 
contractility, and proper response to shear stress. These 
ﬁ  ndings demonstrate that Ena/VASP is critical for actin 
cytoskeleton remodeling events involved in the mainte-
nance of functional endothelia.
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and colocalize with components of adherens and tight junctions 
(Reinhard et al., 1992; Lawrence et al., 2002; Tanoue and 
Takeichi, 2004). In addition to localization to sites involved in 
barrier function, Ena/VASP is a well-established substrate for 
PKA and PKG (Waldmann et al., 1987;  Halbrugge and Walter, 
1989; Haffner et al., 1995). PKA and PKG signaling pathways 
are involved in barrier function regulation, which raises the 
  possibility that Ena/VASP could be a downstream effector of 
these pathways.
At the leading edge of lamellipodia and the tips of fi  lo-
podia, Ena/VASP localizes to regions with dynamic actin re-
organization (Reinhard et al., 1992; Gertler et al., 1996; Lanier 
et al., 1999; Rottner et al., 1999; Lambrechts et al., 2000), where 
it has been proposed to promote actin polymerization via an 
  anticapping mechanism (Bear et al., 2002; Barzik et al., 2005). 
Dynamic actin is also found at focal adhesions and cell–cell 
junctions, and ligation of cell–cell receptors, such as cadherins, 
results in reorganization of the underlying actin cytoskeleton 
(Yonemura et al., 1995; Adams and Nelson, 1998). Disruption 
of Ena/VASP has been shown to reduce the formation of peri-
junctional actin fi  laments (Scott et al., 2006) and perturbs the 
dynamics of epithelial sheet sealing in Drosophila melanogaster 
(Gates et al., 2007). Although these data suggest that Ena/VASP 
regulates actin dynamics at cell–cell and cell–matrix junctions, 
the functional implications of this are unclear.
In mammals, the Ena/VASP family consists of three mem-
bers, mammalian Ena (Mena), VASP, and Ena/Vasp-like (Reinhard 
et al., 1992; Gertler et al., 1996). Because these members have 
overlapping function and expression patterns, knocking out 
  individual family members results in relatively minor pheno-
types in mouse models (Aszodi et al., 1999; Hauser et al., 1999; 
Lanier et al., 1999). To determine the biological function of this 
family of proteins, we have generated an Ena/VASP triple null 
(mmvvee) mouse. mmvvee mice exhibit neuronal defects, in-
cluding exencephaly, cobblestone cortex, and lack of cortical 
 fi ber tract formation, which have previously been characterized 
elsewhere (Kwiatkowski et al., 2007). In addition to these pheno-
types, mmvvee mice display severe vascular defects that are 
 described  here.
Results
mmvvee mice exhibit edema
Gross examination of mmvvee embryos revealed profound edema, 
with 82% of embryos (14 out of 17) at embryonic day (E) 14.5 
appearing edematous to the naked eye (Fig. 1 A). The edema 
was most pronounced in the torso, where transverse sectioning 
showed that it was largely restricted to the subdermal region 
(Fig. 1 B). Edema did not result from exencephaly because we 
observed edematous mmvvee embryos that were not exencephalic 
(unpublished data).
Edema is a common endpoint for a variety of physiological 
defects. Alteration of either hydrostatic or oncotic pressure can 
result from impaired kidney function leading to alterations in 
salt and water handling and/or protein wasting. However, the 
onset of edema in mmvvee embryos was apparent from histo-
logical sectioning as early as E12.5 (unpublished data). At this 
stage in development the embryonic kidney is not functional, 
ruling out kidney dysfunction as the cause of edema.
Embryonic edema can result from cardiac defects (Komatsu 
et al., 2002; Fan et al., 2005; Li et al., 2006). Congenital heart 
defects typically manifest with cardiac dilation and congestive 
heart failure, resulting in increases in the hydrostatic pressure 
within the vascular system, which drive fl  uid into the inter-
stitial tissue. To determine if heart defects could explain the 
edema observed in mmvvee embryos, we analyzed the anat-
omy of the mmvvee embryonic heart. Histologically, mmvvee 
hearts appeared structurally normal (Fig. 2 A) with no sign 
of dilation. Ena/VASP has been implicated in Sema6D signal-
ing events necessary for proper cardiac chamber formation and 
trabeculation (Toyofuku et al., 2004); however, trabeculation 
in the mmvvee heart was normal (Fig. 2 A), and major struc-
tural features of the mmvvee heart, including septum, valves, 
and associated veins and arteries, displayed no defects (not 
depicted). Closer analysis by electron microscopy showed that 
mmvvee cardiac myocytes formed Z lines and intercalated 
Figure 1.  Edema phenotype of mmvvee embryos. (A) mmvvee E14.5 
  embryos exhibit edema (arrow) as compared with littermate control. 
(B) Hematoxylin and eosin staining of transverse histological sections from 
E14.5 embryos. Subdermal region is greatly expanded in mmvvee em-
bryos (arrows).ENA/VASP AND BARRIER FUNCTION • FURMAN ET AL. 763
discs that appeared similar to those of littermate controls 
(Fig. 2, B and C). Although there is no evidence of structural or 
functional heart abnormalities that could explain the edema 
phenotype, we did notice that mmvvee endocardia displayed 
elongated cell membranes and were less closely associated 
with the cardiac myocytes than endocardia in the controls 
(Fig. 2 D). Because the endocardium is the endothelial lin-
ing of the heart, this defect suggested that endothelial dys-
function might be at the root of the edema caused by loss of 
Ena/VASP.
Vessel patterning and integrity are 
compromised in the absence of Ena/VASP
The loss of junctional proteins VE-cadherin, β-catenin, and FAK 
in the endothelia of mice results in edema and the regression 
of blood vessels during development (Carmeliet et al., 1999; 
Cattelino et al., 2003; Shen et al., 2005; Braren et al., 2006). 
To determine the patterning and integrity of blood vessels 
in mmvvee mice, whole mount embryos were stained for the 
endothelial-specifi  c marker platelet/endothelial cell adhesion 
molecule (PECAM) 1, and vessels were found to be grossly 
  intact at E10.5 (Fig. 3 A). Although major vessels appeared 
  normal in mmvvee embryos, there were differences in small 
vessels evident at E10.5, including disruption in connectivity 
between intersomitic vessels in the mid-torso region (Fig. 3 B) 
and irregular patterning in the vascular plexus of the tail (Fig. 3 C). 
These subtle differences in the small vessels of mmvvee em-
bryos are relatively minor in comparison to the vessel disrup-
tion observed in mice that were null for endothelial junctional 
proteins such as β-catenin (Cattelino et al., 2003). Importantly, 
these patterning defects are not the beginning of widespread vas-
cular regression because vessels visualized under a dissection 
microscope were intact in the amniotic sac and body as late as 
E16.5 (Fig. 3, D and E). Vessels in the body and amnion of 
E16.5 mmvvee mice did not exhibit any differences in pattern-
ing or vascular density.
Disruption in endothelial barrier function allows the leak-
age of plasma proteins into the interstitial space. This alters the 
oncotic pressure gradient that normally functions to draw fl  uid 
back into the vasculature, resulting in the accumulation of inter-
stitial fl  uid. A more profound disruption in barrier function 
allows the hemorrhaging of red blood cells. Consistent with a 
role for Ena/VASP in promoting barrier function, we observed spo-
radic hemorrhaging in mmvvee embryos (Fig. 4 A). The earliest 
observations of hemorrhage were at E14.5 and increased through-
out development. Hemorrhaging was also evident by an accu-
mulation of blood in the amnion (Fig. 4 A). Similar to the pattern 
seen in the embryo of edema followed by hemorrhage, analysis 
of embryos at different stages revealed that the amnion fi  rst 
  accumulated excess amniotic fl  uid (Fig. 3 D) followed by 
  hemorrhage. By E18.5, 70% of mmvvee amnions (60 out of 86) 
exhibited an accumulation of blood. Careful examination of 
  recently harvested mmvvee embryos failed to identify an obvi-
ous source of hemorrhage that would account for the accumula-
tion of amniotic blood. Although it is likely that the blood in the 
amnion is caused by hemorrhaging of the amniotic vasculature, 
it is possible that it comes from the embryo itself.
Histological analysis indicated a loss of integrity of small 
blood vessels in mmvvee subdermal tissue (Fig. 4 B). This was 
confi  rmed by transmission electron microscopy, which found 
that 60% of blood vessels (6 out of 10) >10 μm in diameter 
were discontinuous, meaning there was an opening in the endo-
thelial lining and escaping red blood cells (Fig. 4 C). These dis-
continuous vessels were determined to be venules, based on 
size and their lack of surrounding adventitia. In addition to 
discontinuity, mmvvee venules also displayed endothelial cell 
protrusions into the vascular lumen and subendothelial space 
(Fig. 4 C), further suggesting a defect in cell–cell contacts. 
Figure 2.  mmvvee embryonic heart has a thin endocardium. (A) mmvvee 
embryonic hearts are not hypertrophic. Cardiac chambers are not dilated 
and have normal patterns of trabeculation as shown by hematoxylin and 
eosin staining of histological sections. Electron microscopy demonstrates 
formation of Z lines (B, arrows) and intercalated discs (C) in mmvvee em-
bryos. Magniﬁ  ed images of intercalated discs identiﬁ  ed by red rectangles 
are shown under C. (D) The endocardial lining (arrowheads) of mmvvee 
embryonic hearts are thinner than littermate controls and are less closely 
associated with the underlying cardiac myocytes (arrows).JCB • VOLUME 179 • NUMBER 4 • 2007  764
In contrast, no examples of discontinuous capillaries/small 
  arterioles or larger veins and arteries were evident in mmvvee 
embryos. Very small vessels (<10 μm), presumed to be capil-
laries, appeared to be consistently intact in both groups. These 
fi  ndings suggest that hemorrhaging in mmvvee embryos results 
specifi  cally from open venules.
Ena/VASP activity is required for proper 
barrier function
To measure the effect of Ena/VASP on endothelial barrier func-
tion, we used a cell-based assay to test the ability of fl  uorescently 
tagged dextran to cross a confl  uent monolayer of endothelial 
cells. The dextran molecule had a molecular weight compara-
ble to albumin, the chief protein component of blood plasma. 
The isolation and culture of suffi  cient quantities of primary endo-
thelial cells from mmvvee embryonic mice was not possible, 
so we used human umbilical vein endothelial cells (HUVECs) 
for the barrier function assays. Consistent with localization in 
other cell types, Ena/VASP proteins exhibited localization at 
  focal adhesions, stress fi  bers, and cell–cell contacts in HUVECs 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb
.200705002/DC1). Previous studies of the role of Ena/VASP 
on barrier function focused on VASP and relied on the over-
expression of VASP fragments to interfere with VASP function 
(Vasioukhin et al., 2000; Comerford et al., 2002; Lawrence 
et al., 2002) or used siRNA to knock down VASP (Rosenberger 
et al., 2007), which did not eliminate the function of other 
Ena/VASP proteins expressed in endothelial cells (unpublished 
data). To overcome these potential limitations, we used a strat-
egy proven to block the activity of all Ena/VASP family mem-
bers. This approach involves expression of the EGFP-FP4-Mito 
construct that sequesters all Ena/VASP proteins to the surface 
of the mitochondria (Fig. S1 B) and mimics loss of function 
(Bear et al., 2000, 2002; Lebrand et al., 2004). EGFP-FP4-Mito–
  expressing HUVECs were grown to confl  uence and used in 
barrier function assays. When Ena/VASP activity was inhibited, 
basal barrier function was signifi  cantly reduced as compared 
with control HUVECs expressing EGFP or EGFP-AP4-Mito, 
a construct that targets mitochondria but does not sequester 
Ena/VASP (Fig. 5 A). Inhibition of Ena/VASP activity resulted 
in a reduction of barrier function similar to that attained through 
the addition of VEGF, a known permeability enhancing agent, 
to control monolayers (Fig. 5 B). The high permeability of 
Ena/VASP-inactivated monolayers could be further augmented 
with VEGF treatment, indicating that Ena/VASP is not required 
for response to VEGF. Rather, Ena/VASP activity appears to be 
important in the maintenance of basal barrier function. In sup-
port of this, overexpression of EGFP-VASP improved barrier 
function (Fig. 5 B). Collectively, these data are consistent with a 
model in which the edema and hemorrhage observed in mmvvee 
embryos result from defects in endothelial barrier function.
The assembly of cell–cell junction protein 
complexes is unperturbed by the loss of 
Ena/VASP
The defective vascular integrity of mmvvee endothelium and   
reduced barrier function described in the previous sections could 
Figure 3.  Vascular formation and patterning in mmvvee embryos. (A) E10.5 
embryos after whole-mount immunohistochemistry with anti-PECAM anti-
bodies. Major blood vessels are present and intact in the mmvvee embryo. 
(B) Intersomitic vessels appear normal in mmvvee embryos (arrowheads) 
but there is a reduction in connectivity between them (arrows). (C) The vascu-
lar plexus in the mmvvee tail (indicated by brackets and magniﬁ  ed under 
C) exhibits irregular patterning. Images were gamma adjusted. Major vessels 
in the amniotic sac (D) and body (E) of mmvvee embryos appear normal in 
formation and patterning at E16.5. Note the increased volume and turbidity 
of the mmvvee amniotic ﬂ  uid.ENA/VASP AND BARRIER FUNCTION • FURMAN ET AL. 765
result from a failure to recruit the normal complement of cell–
cell junction proteins. In fact, overexpression of a fragment of 
Ena/VASP thought to act as a dominant negative has been shown 
to block E-cadherin recruitment in keratinocytes (Vasioukhin 
et al., 2000). Furthermore, it has been suggested that phosphory-
lation of VASP by PKA is important for ZO-1 recruitment to 
cell–cell junctions (Kohler et al., 2004). To determine if the 
  genetic loss of Ena/VASP affects the recruitment of junctional 
proteins, we isolated primary PECAM-positive endothelial cells 
from the aortae of control and mmvvee embryos and stained for 
junctional components. The resulting small clusters of primary 
endothelial cells showed that localization of PECAM, VE- cadherin, 
β-catenin, α-catenin, and ZO-1 to cell–cell junctions were un-
affected by the absence of Ena/VASP (Fig. 6 A). Immunohisto-
chemistry on tissue sections also showed a normal distribution 
of cell junctional markers in the mmvvee vasculature (unpub-
lished data). Similarly, inactivation of Ena/VASP in HUVECs 
had no effect on the recruitment of the same junctional proteins 
to  established cell–cell junctions (Fig. 6 B) despite the observed 
barrier defects described in the previous section. The recruit-
ment of junctional proteins was also unperturbed by VASP over-
expression (Fig. 6 B).
To test if the kinetics of cadherin-dependent contact forma-
tion was perturbed in the absence of Ena/VASP, we performed 
Figure 4.  Venule discontinuity leads to hemorrhages in mmvvee embryos at later embryonic stages. (A) Sporadic hemorrhages (arrows) in the trunk of 
mmvvee embryos are ﬁ  rst visible around E16.5 and become progressively more prominent (top left). At E18.5 the amnion is ﬁ  lled with blood and can be 
identiﬁ  ed during dissection (mmvvee embryo held with forceps). Bottom shows littermate control and mmvvee embryos in yolk sac with placenta attached. 
(B) Hematoxylin and eosin staining of histological sections show numerous small vessels in mmvvee embryos that contain red blood cells and appear to be 
discontinuous as early as E14.5 (arrowhead). Bar, 10 μm. (C) Electron micrographs of blood vessels indicate that the endothelial junctions in arterioles of 
mmvvee are intact (open arrowheads), but numerous ruptures are present in venules (closed arrowheads) with evidence of escaping red blood cells (asterisk). 
The endothelial cells of these venules displayed extensive cellular lamellipodia protruding in the vascular lumen or extending in the subendothelial space 
(small arrows).JCB • VOLUME 179 • NUMBER 4 • 2007  766
calcium switch assays on HUVEC cultures. Chelation of cal-
cium disrupts the ligation and localization of VE-cadherin at 
cell junctions. After the reintroduction of calcium, the recovery 
rate of VE-cadherin to junctions of Ena/VASP-inactivated cells 
was identical to controls, with localization fi  rst detected after 
30 min and full recovery after 4 h (Fig. 6 C). These results indi-
cate that neither cadherin-mediated adhesion nor the recruit-
ment of junctional proteins to cell–cell contacts are affected by 
the absence of Ena/VASP, which suggests that mislocalization 
or delayed recruitment of junctional proteins does not cause the 
edema observed in mmvvee embryos.
Ena/VASP is important for 
shear stress response
Loss of Ena/VASP activity in primary endothelial cells (Fig. 6 A) 
and HUVEC cultures (Fig. 7 A), either by genetic knockout 
or protein inactivation, respectively, led to a visible reduction 
in F-actin content. This reduction in F-actin was measured with 
microscopy by quantitating the signal intensity of fl  uorescently 
tagged phalloidin (Fig. 7 B). Although overexpression of Ena/
VASP in HUVEC monolayers did not cause a substantial increase 
in F-actin content, it did result in a striking rearrangement of 
actin into parallel ventral stress fi  bers that aligned with each 
other across multiple cell lengths (Fig. 7 A).
The actin reorganization caused by Ena/VASP overexpres-
sion is similar to that induced by shear stress. Under physio-
logical conditions, fl  owing blood subjects endothelial cells to 
shear stress, which has been shown to modulate numerous endo-
thelial cell functions, particularly the strengthening of cell–cell 
junctions and elongation of cell shape in the direction of fl  ow 
(Seebach et al., 2000; Shikata et al., 2005). To determine if the 
cytoskeletal changes that facilitate response to shear stress are 
impaired in the absence of Ena/VASP activity, we cultured Ena/
VASP-inactivated HUVECs in fl  ow chambers. Confl  uent mono-
layers of control HUVECs subjected to shear stress overnight 
responded as expected by forming parallel stress fi  bers but, 
strikingly, Ena/VASP-inactivated HUVECs failed to form stress 
fi  bers (Fig. 7 C). Instead, shear stress appeared to result in a 
slight decrease in the amount of stress fi  bers as compared with 
cells cultured without fl  ow. In contrast, cortical actin staining 
appeared unaffected by inhibition of Ena/VASP. To determine 
if shear stress response was also impaired in mmvvee embryos, 
we looked at actin organization and endothelial cell shape in 
aortae. Control aortae had robust stress fi  bers that ran in the 
  direction of blood fl  ow, whereas the stress fi  bers of mmvvee 
embryos were less organized. Immunostaining for PECAM in 
control aortae revealed a strong linear pattern consistent with 
cells that had elongated in the direction of blood fl  ow,  but 
PECAM staining of endothelial cells in the lining of mmvvee 
aortae was visibly disorganized (Fig. 7 D). These data indicate 
that Ena/VASP is critical for the reorganization of the cytoskele-
ton and changes in cell morphology in response to shear stress.
Actin incorporation and actomyosin 
contractility are affected by Ena/VASP
Biochemical experiments suggest Ena/VASP binds at, or near, 
the barbed ends of F-actin and permits continued incorporation 
of monomeric actin in the presence of capping protein by an-
tagonizing capping activity. We hypothesized that the observed 
changes in F-actin content were attributable to changes in actin 
incorporation at barbed ends. To test this possibility, we pulsed 
permeabilized HUVECs with fl  uorescently labeled monomeric 
actin and measured its incorporation at free barbed ends by 
quantitative microscopy. G-actin incorporation into barbed ends 
was reduced in cells in which Ena/VASP was inhibited and 
  increased upon the overexpression of VASP (Fig. 8, A and B). 
The sites of the greatest barbed end labeling were at the leading 
edges of lamellipodia, focal adhesions,  and along stress fi  bers 
in discrete puncta known as dense bodies, which is consistent 
with previously published results using nonendothelial cell 
types (Kreis et al., 1979). To determine the effect of Ena/VASP 
activity on these different structures, we independently mea-
sured barbed end labeling at the cell periphery (leading edge), 
cell–cell junctions, and internal regions of the cell, where the 
signal was largely caused by incorporation into stress fi  bers. 
Figure 5.  Barrier function is reduced in endothelial cells lacking Ena/
VASP activity. (A) HUVECs expressing FP4-Mito, a construct that inactivates 
Ena/VASP proteins, exhibit an increase in the movement of Texas red–
  dextran across conﬂ  uent monolayers compared with control cells express-
ing GFP or AP4-Mito, a mutated version of the sequestration construct that 
targets the mitochondria but is incapable of binding Ena/VASP proteins 
(*, P < 0.05; n = 6). Error bars represent SD. (B) Stimulation of HUVEC 
monolayers with VEGF increases the permeability of control monolayers to 
levels similar to FP4-Mito monolayers without VEGF treatment. Overexpression 
of VASP decreases permeability compared with GFP control. VEGF treat-
ment further reduces barrier function of FP4-Mito monolayers as compared 
with FP4-Mito without VEGF treatment (*, P < 0.05; n = 3). Error bars 
  represent SD.ENA/VASP AND BARRIER FUNCTION • FURMAN ET AL. 767
Figure 6.  Ena/VASP is not required for proper localization of junctional proteins. (A) Junctional proteins, as indicated, localize to cell junctions in primary 
endothelial cells isolated from mmvvee and control embryonic aortae. No obvious changes in intensity or localization of junctional proteins are evident, al-
though there is a decrease in stress ﬁ  bers in mmvvee cells. Bar, 10 μm. (B) Localization of junctional proteins VE-cadherin, ZO-1, and β-catenin is unaffected 
by Ena/VASP inactivation in HUVECs, although the morphology of cell–cell junctions is altered. Inactivation of Ena/VASP results in a smoother appearing 
junction, whereas junctions are highly striated in HUVECs overexpressing Ena/VASP. Bar, 50 μm. (C) VE-cadherin recovery to cell junctions after calcium 
switch is unaffected by Ena/VASP. HUVECs were grown to conﬂ  uence and treated with 5 mM EGTA for 30 min to disrupt adherens junctions. EGTA was 
washed out and cells were allowed to recover for the indicated times, followed by ﬁ  xation and immunoﬂ  uorescence for VE-cadherin. Recovery rates of 
VE-cadherin were indistinguishable between control HUVECs and HUVECs with altered Ena/VASP activity. Bar, 50 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  768
Figure 7.  Stress ﬁ  ber formation is affected by Ena/VASP activity. (A) Inactivation of Ena/VASP in conﬂ  uent HUVEC monolayers decreases stress ﬁ  ber for-
mation, whereas overexpression of Ena/VASP results in the formation of parallel ventral stress ﬁ  bers as compared with controls. Bar, 50 μm. Stress ﬁ  bers 
at regions of cell–cell junctions colocalize with the junctional marker β-catenin (inset). (B) Box-and-Whisker plots of the decrease of F-actin in Ena/VASP-
  inactivated HUVECs and mmvvee primary aorta endothelial cells (*, P < 0.05; n = 20). Despite changes in actin architecture, total F-actin content is not 
  altered in HUVECs overexpressing VASP. The middle line of the box indicates median, the top of the box indicates 75th quartile, the bottom of the box indi-
cates 25th quartile, and whiskers extend to the highest and lowest values. (C) HUVECs expressing FP4-Mito fail to form stress ﬁ  bers in response to shear ENA/VASP AND BARRIER FUNCTION • FURMAN ET AL. 769
Barbed end labeling at all of these sites was found to be sensi-
tive to Ena/VASP activity, although the most profound effect 
was observed along stress fi  bers, with signal being frequently 
undetectable in cells expressing FP4-Mito (Fig. 8 A). This same 
pattern was found using dissociated primary endothelial cells, 
with barbed end incorporation reduced in cells from mmvvee 
aorta as compared with littermate controls (Fig. 8 C). Ena/VASP 
has previously been described to decorate stress fi  bers in   discrete 
puncta (Reinhard et al., 1992; Boukhelifa et al., 2004), a local-
ization we confi  rmed in both HUVECs and primary endothelial 
cells (Fig. S1, A and C). Higher resolution analysis of stress 
 fi bers showed that GFP-VASP localizes in puncta that overlap 
with, or are immediately adjacent to, regions of barbed end 
  labeling (Fig. 8 D). Puncta were spaced at a mean of 0.852 ± 
0.285 μm from each other, a distribution that was unaffected by 
Ena/VASP activity. The colocalization of Ena/VASP and sites 
of G-actin incorporation along stress fi  bers, and the reduction of 
G-actin incorporation in stress fi  bers upon the inactivation of 
Ena/VASP, indicates that Ena/VASP promotes actin monomer 
incorporation along stress fi  bers.
Stress fi  bers are associated with the generation of contrac-
tile forces within the cell. Other proteins known to localize in 
puncta along stress fi  bers include α-actinin, fi  lamin, tropomyo-
sin, and myosin, all of which are involved in actomyosin con-
traction (Lazarides and Burridge, 1975; Gordon, 1978; Kreis 
and Birchmeier, 1980; Byers et al., 1984; Drenckhahn and 
  Wagner, 1986; Svitkina et al., 1989). Because the actin stress   fi  ber 
rearrangements that accompany Ena/VASP overexpression are 
similar to those observed in highly contractile cells, we measured 
the expression of myosin light chain (MLC) in cells with altered 
Ena/VASP activity. Ena/VASP overexpression increased levels 
of MLC over that in controls, whereas inactivation of Ena/VASP 
reduced MLC expression (Fig. 9, A and B). These changes in the 
level of MLC expression were accompanied by changes in MLC 
phosphorylation that have been shown to be indicative of en-
hanced actomyosin contraction (Sobieszek, 1977).
To determine if changes in MLC expression and phosphory-
lation state had the predicted effect on actomyosin contraction, 
we seeded endothelial cells into three-dimensional collagen 
matrices and used matrix compaction as an indication of the 
force exerted upon the collagen by the cells. Consistent with 
  activation of MLC, HUVECs overexpressing Ena/VASP exerted 
more force on the collagen, whereas Ena/VASP-inactivated cells 
were less contractile than controls (Fig. 9 C).
Ena/VASP activity alters 
junction morphology
Cell–cell and cell–matrix contacts attach to the actin cytoskeleton 
and are infl  uenced by force exerted on them through actomyo-
sin contraction. Although the recruitment of adherens and tight 
junction proteins to cell–cell contacts was not altered by Ena/
VASP activity, the gross morphology of the junction was affected. 
In less contractile Ena/VASP-inactivated HUVECS, staining for 
junctional marker proteins VE-cadherin, ZO-1, and β-catenin 
revealed junctions that were slightly smoother than in controls, 
whereas Ena/VASP overexpression resulted in a striated ap-
pearance of junctions, which is indicative of increased force 
generation (Figs. 6 B and 7 A). These results show that the 
shape of cell–cell junctions is altered by Ena/VASP activity, 
presumably through an increase in actomyosin contraction. The 
application of tension upon cell junctions by the cytoskeleton is 
necessary for the formation and maintenance of junctions in a 
process known as force strengthening. Thus, reduction of acto-
myosin contraction in the absence of Ena/VASP may interfere 
with force strengthening, resulting in the observed barrier func-
tion defects.
Discussion
Mice lacking Ena/VASP proteins develop edema and hemorrhage, 
which lead to embryonic lethality. Edema and hemorrhage 
can both result from disruption in endothelial barrier function, 
which we show is decreased upon Ena/VASP inactivation in 
a cell-based barrier function assay. Barrier function depends 
on the formation and maintenance of cell–cell contacts, which 
  interact with one another and the underlying cytoskeleton. Loss of 
Ena/VASP activity reduces stress fi  ber formation, impairs shear 
stress response, and inhibits actomyosin contraction. Relaxation 
of the actin cytoskeleton in the absence of Ena/VASP activity 
may result in weak cell–cell junctions that do not strengthen 
  appropriately, culminating in the barrier function defects ob-
served in mmvvee mice.
Ena/VASP and cardiac function
Edema can arise from several conditions, including late stage 
heart failure. A previous study has shown that displacement of 
Ena/VASP by cardiac-specifi  c expression of the VASP-EVH1 
domain causes dilated cardiomyopathy, bradycardia, and myocyte 
hypertrophy (Eigenthaler et al., 2003). Furthermore, the hearts of 
Mena-null mice develop structural and electrical conductivity 
abnormalities postnatally (unpublished data). In contrast, hearts 
from mmvvee embryos appear to form normal Z lines and inter-
calated disks and are not enlarged, suggesting that a heart defect 
is not the primary cause of the edema. The discrepancy between 
our work and other studies may arise because of off-target effects 
of the dominant-negative systems used to inhibit Ena/VASP 
function, or the phenotypes may be restricted to postnatal animals. 
Mena-dependent heart defects that develop later in life may 
  result from failure of cardiac myocytes to adapt to normal 
postnatal cardiac stresses. The only defect we observed in the 
mmvvee embryonic heart was a thinning and detachment of the 
endocardium. This phenotype is strikingly similar to that seen in 
the β-catenin conditional knockout mouse (Cattelino et al., 2003), 
suggesting a defect in cell–cell contacts.
stress (10 dyne/cm
2, 16–20 h). Magniﬁ  ed images identiﬁ  ed by red rectangles are shown (bottom). Flow direction is indicated by arrow. Images are 
gamma adjusted. Bar, 50 μm. (D) Confocal micrographs of phalloidin- and anti-PECAM–labeled dorsal aortae show that cells in the endothelial lining of 
mmvvee aortae fail to form stress ﬁ  bers and elongate in the direction of ﬂ  ow. Bar, 10 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  770
Figure 8.  G-actin incorporation is reduced in cells lacking Ena/VASP activity. (A) Fluorescent images showing F-actin (phalloidin) and sites of recent G-actin 
incorporation at barbed ends. G-actin incorporation at barbed ends is highest at the cell periphery and stress ﬁ  bers and is visibly reduced in stress ﬁ  bers 
by Ena/VASP inactivation. Overexpression of Ena/VASP proteins increases G-actin incorporation. Incorporation at barbed ends in HUVECs expressing 
AP4-Mito was comparable to the EGFP control. Bar, 50 μm. (B) Box-and-Whisker plots of total cellular F-actin content and G-actin incorporation in HUVECs 
(n > 23). Peripheral measurements were taken from the ﬁ  rst 5 μm, starting at the cell edge of subconﬂ  uent cells. F- and G-actin content in cell junctions un-
der conﬂ  uent conditions were measured by linescan (n = 40). (C) Box-and-Whisker plots of F-actin content and G-actin incorporation in internal regions 
and cell–cell junctions of primary endothelial cells. Actin incorporation was reduced in cells derived from mmvvee embryos as compared with littermate 
controls (n > 17). The middle line of the box indicates median, the top of the box indicates 75th quartile, the bottom of the box indicates 25th quartile, 
and whiskers extend to the highest and lowest values. (D) Higher resolution images of stress ﬁ  bers (blue) show that G-actin (red) incorporation occurs in dis-
crete punta that colocalize with EGFP-VASP (green). Bar, 25 μm. *, P < 0.05.ENA/VASP AND BARRIER FUNCTION • FURMAN ET AL. 771
Barrier function and cell–cell junctions
Although knockout mice lacking individual members of the 
Ena/VASP family do not exhibit barrier defects, our work 
shows that simultaneous knockout of all three Ena/VASP fam-
ily members results in severe endothelial barrier disruption. 
These in vivo fi  ndings are consistent with earlier studies that 
suggested a link between VASP and barrier function (Sporbert 
et al., 1999; Comerford et al., 2002; Lawrence et al., 2002). 
Several signaling pathways that reduce barrier function result 
in the phosphory  lation of VASP by PKG, raising the possibil-
ity that Ena/VASP is an important downstream target in bar-
rier function regulation. VEGF is one agent that activates nitric 
oxide/PKG signaling and results in VASP phosphorylation. 
However, Ena/VASP-inactivated cells have an intact response 
to VEGF, which suggests that, at least in the case of VEGF sig-
naling, phosphorylation of VASP by PKG is not required for 
barrier function modulation.
A recent study has shown that VASP is down-regulated in 
response to hypoxic conditions, providing another mechanism 
for Ena/VASP family members to regulate barrier function 
(Rosenberger et al., 2007). Targeting of VASP by siRNA re-
duced barrier function in human microvascular endothelial 
cells, whereas overexpression of VASP increased basal barrier 
function and protected cells from hypoxia-induced barrier dis-
ruption. The VASP-null mouse, however, does not exhibit signs 
of barrier disruption such as edema, likely because of the pres-
ence of the highly related Mena and Ena/Vasp-like proteins in 
the mouse vasculature.
Although Ena/VASP has been implicated in the regulation 
of barrier function, its mechanism of action is poorly under-
stood. It has been proposed that Ena/VASP is essential for 
proper recruitment of cell junction proteins, potentially explain-
ing its importance for barrier function (Vasioukhin et al., 2000; 
Lawrence et al., 2002; Kohler et al., 2004). Indeed, genetic 
  ablation of several proteins involved in cell–matrix (FAK) or cell–
cell contacts (β-catenin and VE-cadherin) results in edematous 
hemorrhagic phenotypes that are similar to those in mmvvee mice 
(Carmeliet et al., 1999; Cattelino et al., 2003; Shen et al., 2005; 
Braren et al., 2006). Nevertheless, we see no evidence of a failure 
to recruit junctional proteins in either primary endothelial cells 
lacking Ena/VASP proteins or Ena/VASP-inactivated HUVEC 
cultures, suggesting that barrier disruption caused by loss of 
Ena/VASP does not impair junction formation.
Underlying cause of barrier function defect
Dynamic actin has been implicated in the maintenance of barrier 
function, particularly peripheral cortical actin, which is proximal 
to cell junctions. As actin regulators, Ena/VASP proteins have 
been proposed to affect barrier function through modulation 
of actin dynamics. Using a G-actin barbed end incorporation 
assay, we found that loss of Ena/VASP activity leads to only a 
modest reduction in incorporation at the cell periphery, includ-
ing regions of cell–cell junctions. This suggests that changes in 
cortical actin dynamics do not explain the role of Ena/VASP on 
barrier function. We did fi  nd that G-actin incorporation along 
barbed ends within stress fi  bers was dramatically reduced in 
the absence of Ena/VASP activity, whereas cells overexpressing 
Ena/VASP had increased barbed end labeling and formed large 
ventral stress fi  bers. Our results provide a mechanistic expla-
nation for the previous report that VASP overexpression in 
  bovine aortic endothelial cells increased stress fi  bers (Price 
and Brindle, 2000). Ena/VASP-induced parallel ventral stress 
fibers mimic actin cytoskeletal rearrangements that occur in 
response to shear stress and actomyosin contraction. Indeed, VASP 
  overexpression increased actomyosin contraction, whereas cells 
lacking Ena/VASP activity were less contractile than control 
cells. Ena/VASP-defi  cient cells also failed to reorganize their 
stress fi  bers or alter cell morphology in response to shear stress, a 
defect we confi  rmed in vivo in the endothelial lining of aorta from 
mmvvee mice. These fi  ndings are consistent with the hypothesis 
that Ena/VASP may be a downstream component of the zyxin-
dependant mechanosensory mechanism (Yoshigi et al., 2005). 
Figure 9 .  Ena/VASP activity affects actomyosin contractility. (A) Western 
blots with antibodies to total or phosphorylated MLC show that inactivation 
of Ena/VASP in HUVECs reduces the level of MLC expression, whereas 
cells overexpressing Ena/VASP have higher levels of MLC expression. 
(B) Quantitation of total and phospho MLC (*, P < 0.05; n = 5). Error bars 
represent SD. (C) HUVEC cells with inactivated Ena/VASP exert less force, 
as measured by contraction of collagen matrices, whereas overexpression 
of VASP increases force generation compared with GFP control (*, P < 
0.05; n = 10). Contraction of HUVECs expressing AP4-Mito was statisti-
cally indistinguishable from GFP control (not depicted).JCB • VOLUME 179 • NUMBER 4 • 2007  772
Endothelial shear stress response increases barrier function 
(Shikata et al., 2005) and affects signaling pathways, including 
the activation of integrins (Orr et al., 2006). Thus, although 
we have documented the importance of Ena/VASP for barrier 
function under static conditions, impaired response to shear stress 
may exacerbate the barrier defect in mmvvee embryos. VASP 
has been shown to become transiently phosphorylated in cells 
subjected to shear stress before undergoing actin rearrange  ment 
(Wei et al., 2003), suggesting that Ena/VASP response to shear 
stress may be phosphoregulated.
Stress fi  ber formation is regulated by the small GTPase 
Rho (Ridley and Hall, 1992). Rho is involved in the regulation 
of numerous processes, including cell–cell contact function and 
barrier function maintenance (Nusrat et al., 1995; Braga et al., 
1997, 1999; Carbajal and Schaeffer, 1999), actomyosin contrac-
tility (van Nieuw Amerongen and van Hinsbergh, 2001), and 
actin rearrangement in response to shear stress (Li et al., 1999). 
The overlap of Rho-dependent processes with those affected 
by Ena/VASP suggests that Ena/VASP and Rho may act in the 
same signaling pathway. Ena/VASP did not alter Rho activity as 
measured by Rho pulldown assays (unpublished data), indicat-
ing that if Ena/VASP is in a common signaling pathway with 
Rho, it is probably downstream. Interestingly, other Rho family 
proteins have been proposed to signal through Ena/VASP, 
  particularly Rac1, which has been shown to lead to a transloca-
tion of VASP to cell junctions and to increase barrier function 
(Waschke et al., 2006). Similar to our fi  ndings concerning Rho 
activation, we detected no effect on Rac1 activity by Ena/VASP 
(unpublished data).
Ena/VASP and force strengthening
In addition to increasing F-actin levels, Ena/VASP activity 
may increase actomyosin contractility through up-regulation of 
MLC. MLC expression is regulated by the transcription factor 
serum response factor (Papadopoulos and Crow, 1993; Latinkic 
et al., 2004), which is activated under conditions that reduce 
G-actin pools, including Ena/VASP overexpression (Sotiropoulos 
et al., 1999; Grosse et al., 2003). In the absence of Ena/VASP, 
conditions that would further compromise actomyosin contrac-
tility, stress fi  bers, and F-actin content are reduced.
Actomyosin contractility exerts force on focal adhesions 
and enhances the recruitment of proteins to the adhesion site in 
a process known as force strengthening (Geiger and  Bershadsky, 
2001). Recent work extends the importance of force generation 
to the formation and functioning of adherens and tight junc-
tions (Miyake et al., 2006). Response to shear stress can also be 
thought of as a form of force strengthening and has been shown 
to enhance the strength of cell–cell contacts and thus barrier 
function. Ena/VASP alters the morphology of cell–cell junctions 
in a manner consistent with changes in actomyosin contractility. 
Actomyosin contraction is generally thought to reduce endo-
thelial barrier function by favoring the formation of paracellular 
pores. However, many permeability enhancing agents not only 
stimulate actomyosin contraction but also destabilize cell–cell 
junctions. For example, p21-activated kinase triggers acto-
myosin contraction by phosphorylating MLC (Stockton et al., 
2004) and destabilizes cell–cell junctions through the phosphory-
lation and internalization of VE-cadherin (Gavard and Gutkind, 
2006). Furthermore, activation of MLC has been shown to mediate 
enhanced endothelial barrier function in response to treatment 
with sphingosine 1–phosphate (Dudek et al., 2004) and over-
expression of an inactive MLC mutant reduces epithelial barrier 
function (Gandhi et al., 1997). These observations suggest that 
the relationship between actomyosin contraction and barrier 
function is complex. We speculate that loss of Ena/VASP results 
in a chronic relaxation of force exerted on cell contacts by the 
actin cytoskeleton, leading to a failure of the cell contacts to 
properly strengthen. Impaired cell contacts may fi  rst manifest in 
the vascular system because this is a tissue that exists under 
strong physical stress, resulting in the fl  uid loss and vessel dis-
continuity observed in the mmvvee mouse. Intriguingly, vessel 
rupture appeared to be limited to venules. This subset of the 
vascular bed is responsible for the bulk of transendothelial 
movement of circulating immune cells and plasma. Postcapillary 
venules are particularly sensitive to the barrier function antago-
nists histamine and   bradykinin (Bazzoni and Dejana, 2004), a 
fact potentially explained by the poor organization of tight junc-
tions in this endothelial tissue or the relative lack of supporting 
cells around the venule endothelium. Similarly, the disorganiza-
tion of tight junctions or lack of supporting cells may render ve-
nules particularly sensitive to a reduction in barrier function 
caused by the loss of Ena/VASP.
The ability to modulate endothelial barrier function is 
an important clinical objective because barrier dysfunction 
underlies the morbidity of numerous disease processes, includ-
ing infl  ammation, sepsis, and noncardiogenic pulmonary edema. 
In these processes, an infl  ammatory milieu of cytokines acts 
through several downstream pathways to enhance vascular per-
meability by disruption of cellular junctions and alteration of 
the actin cytoskeleton. Another disease state that exhibits abnor-
mally low endothelial barrier function involves pathological 
vasculature induced by solid tumors. In tumors, barrier dys-
function leads to an increase in interstitial fl  uid pressure in the 
tumor microenvironment, which may interfere with the delivery 
of anticancer drugs to their intended sites. The effi  cacy of anti-
VEGF therapies in combination with chemotherapy has been 
postulated to result from vascular normalization, including an 
increase in tumor barrier function, which enhances delivery of 
chemotherapeutic agents to the tumor. In this work, we demon-
strate that Ena/VASP is critical for barrier function in vivo and 
in vitro. Previous work has identifi  ed Ena/VASP as an end ef-
fector for several converging signaling pathways. This suggests 
that Ena/VASP may provide an attractive therapeutic target to 
modify the morbidity associated with the increased permeabil-
ity observed in a variety of clinical conditions.
Materials and methods
Mice
The generation of Ena/VASP-null (mmvvee) mice has been previously 
  described (Kwiatkowski et al., 2007). All animal work was approved by 
the Massachussetts Institute of Technology Committee on Animal Care. 
Because a single allele of Mena was sufﬁ  cient to prevent the described 
vascular defects, breeding pairs were selected to generate MMvvee or 
Mmvvee littermate controls.ENA/VASP AND BARRIER FUNCTION • FURMAN ET AL. 773
Morphological and histological analysis
Bouin’s ﬁ  xed tissues were embedded in parafﬁ  n, sectioned, and stained 
with hematoxylin and eosin using standard techniques. Sections were im-
aged with a microscope (Eclipse TE300; Nikon) equipped with a digital 
camera (Spot Flex; Diagnostic Instruments, Inc.). Whole mount staining 
was performed using a standard protocol. In brief, E10.5 embryos were 
ﬁ  xed in paraformaldehyde, permeabilized in methanol with DMSO, and 
blocked with hydrogen peroxide. Anti-PECAM1 was used at a 1:20 dilu-
tion (BD Biosciences) and visualized using horseradish peroxidase (Vecta-
stain Elite ABC kit; Vector Laboratories). Stained embryos were imaged 
using a stereoscopic zoom microscope (SMZ-U; Nikon).
Electron microscopy
Tissues were ﬁ  xed with 2.5% glutaraldehyde and 2.5% formaldehyde in 
0.1 M sodium cacodylate–HCl, pH 7.2, for 60–90 min at 4°C, postﬁ  xed 
with 2% osmium tetroxide for 60 min at 4°C, dehydrated in up to 70% 
graded alcohol, and en bloc stained with 0.2% uranyl acetate in 70% 
alcohol for 60 min at 4°C. The samples were then processed for epon 
embedding. Thin epon sections (400 nm) were cut with a diamond knife, 
poststained with uranyl acetate and Reynold’s lead citrate, and viewed 
with an electron microscope (G
2 Spirit BioTWIN; Tecnai) operated at 
80 kV. Digital images were taken with a camera (2k CCD; Advanced 
Microscopy Techniques; provided by the Harvard Medical School Electron 
Microscopy Facility).
Cell isolation and culture
Primary endothelial cells were isolated from the aorta dissected from E14.5 
embryos. Aorta were rinsed in HBSS without calcium and magnesium and 
treated with 1 mg/ml collagenase (Sigma-Aldrich) in primary endothelial 
media for 15 min at 37°C. Collagenase was removed with a PBS rinse and 
aorta were treated with 0.25% trypsin-EDTA (Invitrogen) for 15 min at 
37°C. Aorta were then triterated and passed through a 70-μm cell strainer 
(BD Biosciences), and dissociated cells were plated directly on collagen I–
coated coverslips. Primary endothelial cells were cultured at 37°C in RPMI 
supplemented with 10% fetal calf serum, penicillin/streptomycin, 1 μg/ml 
hydrocortisone, 10 U/ml heparin, 1 μg/ml DMSO, and 0.1 mg/ml endo-
thelial cell growth supplement (Sigma-Aldrich) and used for experiments 
within 48 h. HUVECs (Cascade Biologics) were maintained on collagen I–
coated dishes in endothelial basal media–2 (Clonetics). Cells expressing 
EGFP control, EGFP-Ena/VASP proteins, EGFP-FP4-Mito, and EGFP-AP4-Mito 
constructs were generated using vesicular stomatitis virus G–pseudotyped retro-
viruses as previously described (Bear et al., 2000; Furman et al., 2002). 
Infected HUVECs were FACS sorted for equivalent levels of expression and 
used in cell-based assays between passages ﬁ  ve and eight.
Immunoﬂ  uorescence
Cells were plated onto collagen I–coated coverslips and ﬁ  xed with warmed 
4% paraformaldehye/0.25% gluteraldehyde in Krebs-Ringer solution with 
0.4 M sucrose. Cells were blocked in 10% BSA/PBS, extracted with 0.2% 
Triton X-100 for 3 min, and stained with indicated primary antibodies. Alexa-
phalloidin (Invitrogen) was used at 1:50 dilution and Alexa-conjugated 
secondary antibodies were used at 1:1,000 (Invitrogen).
Anti–VE-cadherin and anti-PECAM (Becton Dickinson), anti-ZO1 
(Chemicon), anti–α-catenin (Invitrogen), and anti–β-catenin (Sigma-Aldrich) 
were used for staining primary endothelial cells. Anti–VE-cadherin antibody 
(Chemicon) was used for HUVEC cultures. Images were acquired with a 
  microscope (Deltavision [Carl Zeiss, Inc.]; Eclipse TE300 [Nikon]) and decon-
volved using processing software (Softworx; Applied Precision) or a digital 
camera (Orca-ER; Hamamatsu). Descending aorta were dissected from 
E14.5 embryos, ﬁ  xed with 4% paraformaldehyde in PBS for 2 h, immuno-
stained with anti-PECAM antibody, and imaged with a microscope (TE2000; 
Nikon) equipped with a spinning disk confocal head (Yokagawa), a 
Lambda 10–2 multiposition ﬁ  lter wheel (Sutter Instrument Co.), and a cam-
era (Orca-ER cooled CCD; Hammamatsu). This system was coupled to a 
multi-band laser (Innova 70C 2.5W; Coherent). Wavelengths were selected 
with separate excitation and emission ﬁ  lters (Chroma Technology Corp.) 
in the ﬁ  lter wheels. All hardware was controlled by Metamorph software 
(Invitrogen). Aorta images are maximum projections of ﬁ  ve consecutive 
1-μm planes, using a Plan Apo objective (60×/1.40 DIC; Nikon).
Shear stress
HUVECs were seeded at conﬂ  uence in ﬁ  bronectin-coated Ibidi μ-slide VI ﬂ  ow 
through chambers (Integrated BioDiagnostics). 10 dynes/cm
2 of laminar shear 
stress was applied to cells for 16 to 20 h by ﬂ  owing media through a loop 
consisting of a media reservoir, peristaltic pump, and compliance chamber. 
Cells were ﬁ  xed in warm 4% paraformaldehyde and stained with Alexa-
phalloidin. Images were captured with a microscope (Eclipse TE300) using 
a Plan Fluor objective (10×/0.3; Nikon).
G-actin incorporation assay
HUVECs and primary mouse endothelial cells were plated on collagen-
coated coverslips, and the rate of G-actin incorporation at barbed ends 
was determined using a previously described technique (Symons and 
Mitchison, 1991). In brief, cells were permeabilized with 0.125 mg/ml 
saponin in the presence of 0.5 mM Alexa 568–conjugated G-actin (Invitro-
gen). After a 2-min labeling period, samples were ﬁ  xed in 0.5% glutar-
aldehyde, permeabilized with 0.5% Triton X-100, and blocked in the 
presence of Alexa 350–phalloidin (Invitrogen). Images were acquired with 
a microscope (Eclipse TE300) using a Plan Flour objective (40×/1.30 
DIC; Nikon). Cellular F- and G-actin content was quantitated using Meta-
morph software.
MLC quantitation
HUVEC cultures were maintained on collagen-coated 10-cm
2 plates at con-
ﬂ  uence for 3 d, lysed in SDS sample buffer, sonicated for 10 s, and sub-
jected to SDS-PAGE. Western blot analysis was performed using antibodies 
to total and Serine19 phosphorylated MLC 2 (Cell Signaling Technology). 
Blots were probed with anti-RhoA (Cytoskeleton, Inc.) and anti-actin (Chem-
icon) antibodies to ensure equivalent loading.
Contraction assay
10
6 cells/ml of HUVECs were suspended in 2 mg/ml of type I collagen 
and cast in 200-μl discs as previously described (Sieminski et al., 2004). 
Projected areas of collagen gel discs were measured immediately after 
  release from molds and after 2 d of culture in endothelial basal media 
  supplemented with 50 ng/ml VEGF (R&D Systems), basic ﬁ   broblast 
growth factor (R&D Systems), and phorbol myristate acetate (Sigma-Aldrich) 
for 2 d.
Permeability assay
HUVECs were seeded at conﬂ  uence on polycarbonate transwell membrane 
inserts (Corning 3402) and cultured for 3 d. 70 kD of Texas red–dextran 
(Invitrogen) was added to the top chamber at 2 mg/ml, and its movement 
into the bottom chamber was monitored over 4 h by spectrophotometer.
Statistical analysis
Statistical differences between two conditions were determined using t test. 
For multiple conditions, means were compared by analysis of variance. All 
data found to be signiﬁ  cant (P < 0.05) by analysis of variance were com-
pared with Tukey’s honestly signiﬁ  cant difference post hoc test to reveal 
statistically different groups.
Online supplemental material
Fig. S1 shows the localization of endogenous VASP at cell–cell junctions 
and stress ﬁ  bers in HUVEC and primary endothelial cell cultures. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200705002/DC1.
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